Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis

Ann Hematol. 2004 Oct;83(10):646-53. doi: 10.1007/s00277-004-0922-3. Epub 2004 Aug 14.

Abstract

Evaluating the functional consequences of prostate apoptosis response gene-4 (par-4) expression in CD95-induced apoptosis of neoplastic lymphocytes, we demonstrate that par-4 increases apoptosis by upregulating the CD95 receptor on the cell surface and--with a concomitant decrease of the FLICE-like inhibitory protein (FLIP)--by promoting cleavage of the initiator caspases-8 and -10. This results in an enforced activation of the executioner caspases-6, -7, and -3 as well as in an activation of the mitochondrial pathway. Upon inhibition of caspase-8, overexpression of par-4 enables Jurkat cells to maintain a higher sensitivity to CD95-induced apoptosis by downregulating cIAP-2 and XIAP and by enforcing activation of the initiator caspase-10 as well as of the executioner caspases-6, -7, and -3.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / immunology*
  • Apoptosis Regulatory Proteins
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • Fas Ligand Protein
  • Humans
  • Intracellular Signaling Peptides and Proteins*
  • Jurkat Cells
  • Lymphocytes / enzymology
  • Lymphocytes / immunology
  • Lymphocytes / pathology*
  • Male
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / metabolism
  • Prostate / enzymology
  • Prostate / pathology*
  • fas Receptor / metabolism
  • fas Receptor / physiology*

Substances

  • Apoptosis Regulatory Proteins
  • Carrier Proteins
  • FASLG protein, human
  • Fas Ligand Protein
  • Intracellular Signaling Peptides and Proteins
  • Membrane Glycoproteins
  • fas Receptor
  • prostate apoptosis response-4 protein